Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic hepatitis C drug therapy update].

R Ruano Camps1, C Gallego Fernández

  • 1Servicio de Farmacia. Hospital General Carlos Haya. Málaga. Spain.

Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria
|February 21, 2004
PubMed
Summary

Hepatitis C Virus (HCV) treatment has improved, with newer therapies achieving 55% sustained viral response (SVR). However, these advanced treatments significantly increase pharmaceutical costs, necessitating careful management within hospital drug policies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Appropriateness of antimicrobial prescriptions in the emergency department of a tertiary hospital].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2018
Same author

[Effectiveness of plerixafor in patients undergoing mobilization autologous haematopoietic progenitor cell].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2013
Same author

[The role of the hospital pharmacist in the prevention, treatment and management of the side effects associated with antiretroviral treatment].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2010
Same author

[Infliximab in rheumatoid arthritis-use in a third level hospital].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2005

Area of Science:

  • Hepatology
  • Virology
  • Pharmacoeconomics

Context:

  • Chronic Hepatitis C Virus (HCV) infection presents significant global health and economic challenges.
  • Current treatment aims for sustained viral response (SVR), signifying disease cure.

Purpose:

  • To review the advancements in Hepatitis C Virus (HCV) treatment efficacy and associated financial implications.
  • To emphasize the need for rational drug use policies and established protocols for managing novel HCV therapies.

Summary:

  • Therapeutic efficacy for chronic hepatitis C has advanced from 15% SVR with interferon monotherapy to 55% SVR with pegylated interferons and ribavirin.
  • Patient stratification by genotyping and viral load influences treatment outcomes.
  • These improved outcomes are linked to substantial increases in pharmaceutical expenditure.

Related Experiment Videos

Impact:

  • The rising cost of effective HCV treatments necessitates their inclusion in hospital pharmacotherapeutic guides.
  • Development of clear usage criteria and therapeutic protocols is crucial for rational drug use and cost containment.
  • Effective pharmacotherapeutic monitoring is essential for optimizing patient outcomes and managing healthcare resources.